CLINICAL_TRIALS
research
· 2017-04-10
Clinical Trial Update: Pharmacodynamic Equivalence of Ramipril 10 mg and Atorvastatin 40 mg Administered as a Cardiovascular (CV) Polypill Acetylsalicylic Acid-Atorvastatin-Ramipril (AAR) as Compared to Monotherapy [Phase 2]
Summary
This Phase 2 trial assesses pharmacodynamic equivalence of a cardiovascular polypill (AAR: acetylsalicylic acid-atorvastatin-ramipril) versus monotherapy in hyp…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ferrer Internacional S.A. | Conditions: Hypertension | Phase 2 | Status: UNKNOWN